v3 Template
K

Kadimastem Ltd.

Biotechnology ~340 employees
Founded
--
Employees (Est.)
~340
17 leaders known
Total Funding
$2.1M
Funding Rounds
1
Last Funding
2023-01-09

About Kadimastem Ltd.

Kadimastem is a clinical-stage biotechnology company based in Israel, focused on developing innovative and groundbreaking cell therapy treatments. Their mission is to become a global leader in cell therapy, providing regenerative therapies for incurable diseases to help millions of patients worldwide.

Products & Services

Cell Therapy Platform:A unique platform for producing off-the-shelf cell-based products to address unmet medical needs.
Neurology Treatments:Therapies targeting neurological conditions as part of their product pipeline.
Diabetes Treatments (ITOL-102):Therapies aimed at treating diabetes, supported by the BIRD Foundation.

Specialties

Cell Therapy Regenerative Medicine Neurology Diabetes Treatment Gene-Edited Therapies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Rights Offering
T: -
FT: Rights Offering 		A: 2142857
MR: -
FA: 7.5 million NIS
FAN: 2142857 		D: 2023-01-09
FD: 2023-01-09 		3 investors
Rights Offering Latest
2023-01-09
$2.1M
3 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Michel Revel

Professor

B

Benjamin Reubinoff

Professor

E

Eddy Karnieli

Professor, MD

D

Danielle Melloul

Professor

T

Tamir Ben Hur

Professor of Neurology and Chairman, The Department of Neurology, Hadassah - Hebrew University Medical Center

J

Joseph Itskovitz-Eldor

Professor

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Kadimastem Ltd. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~340 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro